Abstract: Methods, systems, devices, and tangible non-transitory computer readable media facilitating assignment and/or dynamic application of a permission rule to a group of entities. In an example embodiment, the disclosed technology can: define a group of entities having a common attribute; assign a permission rule to the group of entities based at least in part on the common attribute; project the permission rule onto one or more entities in the group of entities based at least in part on assignment of the permission rule to the group of entities; obtain data indicative of a change in group membership status of an entity in the group of entities; and/or update a projection of the permission rule onto the entity to modify an association of the entity with the group of entities and/or the permission rule based at least in part on receipt of the data.

Abstract: Methods of forming and processing semiconductor devices are described. Certain embodiments related to electronic devices which comprise a dipole region having an interlayer dielectric, a high-? dielectric material, and a dipole layer. The dipole layer comprises one or more of titanium aluminum nitride (TiAlN), titanium tantalum nitride (TiTaN), titanium oxide (TiO), tantalum oxide (TaO), and titanium aluminum carbide (TiAlC).

Abstract: The disclosed technology addresses the problem of testing performance of RU scheduling algorithms used by an OFDMA enabled AP to support multiple clients, using a two-armed test harness with a wired connection to one side of an AP under test and multiple wireless clients coupled in RF communication with the AP. The wireless clients can be connected over the air or conductively to antenna(s) of the AP under test. The test harness generates test traffic. A sniffer radio listens to RU allocation and schedules traffic broadcast by the AP to multiple clients. A recording module records the RU allocation and traffic and a report generator categorizes the recorded resource allocation with the scheduling traffic heard by the sniffer radio and provides resource allocation statistics. The wireless clients are connected conductively or OTA to antennas of the AP under test. One sniffer radio replaces multiple sniffers used in prior test systems.

Abstract: There is provided a cleaning apparatus for the base of a toilet. The apparatus includes an inner peripheral portion for extending at least partially around the base of the toilet. The apparatus includes an outer peripheral portion spaced-apart from the inner peripheral portion. The apparatus includes an arcuate-shaped top portion extending from the inner peripheral portion to the outer peripheral portion. According to another aspect, there is provided a cleaning apparatus for the base of a toilet. The apparatus includes an absorbent member that is biased upwards and which may be selectively lowered to abut a location adjacent to the base of the toilet for absorbing fluid.

Abstract: Compounds and compositions are provided for treatment, prevention, or amelioration of a variety of medical disorders associated with viral infections and/or cell proliferation. The compounds provided herein are nucleoside phosphonates and esters thereof.

Abstract: A specially engineered composite fiber is provided that is a combination of weight imparting particles and polymeric compounds, with a specific gravity totaling about 2 or greater. The composite fiber can be extruded and melt-spun like a normal polymeric fiber, thus creating a relatively heavy, weighted material fiber, sheet or fabric.

Abstract: Lipid-modified phosphodiester nucleoside prodrugs are described herein. The prodrugs can be used to treat viral infections and cancer.

Abstract: Leptomycin-type compounds according to formula I wherein R0, R1, R2, R10, R11, R12, R13, R14, and m are as defined herein, exhibit anti-tumor activity.

Abstract: Leptomycin-type compounds according to Formula I wherein R0, R1, R2, R10, R11, R12, R13, R14, and m are as defined herein, exhibit anti-tumor activity.

Abstract: Leptomycin-type compounds according to Formula I wherein R0, R1, R2, R10, R11, R12, R13, R14, and m are as defined herein, exhibit anti-tumor activity.

Abstract: The present invention provides 14-methyl epothilone compounds, along with intermediates thereto, methods for their preparation, compositions comprising the compounds, and methods for their use in the treatment of cancer and other diseases and conditions characterized by undesired cellular hyperproliferation.